May 20, 2024 | HighField Bio Press Release

American Diabetes Association
2024 Scientific Meeting
June 21-24, Orlando

HighField Bio Founder and CEO, Yuhong Xu will present a poster on June 22nd.

Abstract Title:  Preliminary Study of Efficacy and Duration of an mRNA-Based GLP-1R Agonist in Diabetic Monkeys. (Poster presentation number 1860-LB in category 12-B Clinical Therapeutics-Incretin-Based Therapies).

Presenter:  Dr. Yuhong Xu, HighField CEO

Presentation:  Saturday, June 22, 2024, 12:30 pm – 1:30 pm EDT (The poster will be displayed Saturday, Sunday and Monday in the Poster Hall; and at a Networking Reception Friday evening.)